Cyclica Revenue and Competitors
Estimated Revenue & Valuation
- Cyclica's estimated annual revenue is currently $852.5k per year.
- Cyclica's estimated revenue per employee is $77,500
- Cyclica's total funding is $23.8M.
Employee Data
- Cyclica has 11 Employees.
- Cyclica grew their employee count by -83% last year.
Cyclica's People
Name | Title | Email/Phone |
---|---|---|
1 | Co-Founder, President and CEO | Reveal Email/Phone |
2 | General Counsel and Corporate Secretary | Reveal Email/Phone |
3 | VP Corporate Development | Reveal Email/Phone |
4 | VP, Drug Discovery | Reveal Email/Phone |
5 | Chief Financial Officer | Reveal Email/Phone |
6 | Director, Machine Learning | Reveal Email/Phone |
7 | Associate Director Legal | Reveal Email/Phone |
8 | Chief Science Officer, Head Drug Discovery | Reveal Email/Phone |
9 | Manager, People and Operations | Reveal Email/Phone |
10 | Software Developer | Reveal Email/Phone |
Cyclica Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.7M | 9 | -72% | $39.4M | N/A |
#2 | $0.9M | 11 | -83% | $23.8M | N/A |
#3 | $87.6M | 565 | 6% | N/A | N/A |
#4 | $2.8M | 18 | 13% | N/A | N/A |
#5 | $7.8M | 50 | -68% | N/A | N/A |
#6 | $13.5M | 87 | 30% | N/A | N/A |
#7 | $17.8M | 115 | -6% | N/A | N/A |
#8 | $0.9M | 11 | -39% | N/A | N/A |
#9 | $13.6M | 88 | -20% | $86M | N/A |
#10 | $20M | 129 | -12% | N/A | N/A |
What Is Cyclica?
Cyclica is decentralizing the discovery of better medicines by combining its deep roots in Artificial Intelligence (AI) and protein biophysics with an innovative business model
keywords:N/A$23.8M
Total Funding
11
Number of Employees
$852.5k
Revenue (est)
-83%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Cyclica News
Cyclica and Arctoris have expanded their partnership to progress drug discovery programs for novel neurodegenerative targets, focusing on...
TORONTO & OXFORD, England--(BUSINESS WIRE)--Cyclica Inc. (Cyclica), a neo-biotech with the vision to advance the most robust and...
Cyclica started out licensing its drug-design software to biopharma companies, but it quickly realized that route was “simply not inspiring.” Rather than zeroing in on a particular disease area like a traditional biotech or teaming up with a Big Pharma like other drug discovery outfits, the Toro ...
Biotech startup Cyclica has raised $23 million CAD in Series B financing. The company offers a drug discovery platform that leverages artificial intelligence and computational biophysics. The equity round, which closed around the end of April, was led by Columbus, Ohio-based Drive Capital. Ital ...
Cyclica, a Toronto, Canada-based neo biotech company, closed a CAD$23M Series B round of financing. The round was led by Drive Capital with participation from Chiesi Farmaceutici, GreenSky Capital, and members of Cyclica’s management team. The company intends to use the funds for continued inn ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.7M | 11 | -58% | $16.9M |
#2 | $2.2M | 11 | 0% | N/A |
#3 | $0.7M | 11 | 0% | $34.4M |
#4 | $1.4M | 11 | -45% | N/A |
#5 | $1.4M | 11 | 0% | N/A |